Evidence map›Paper›PMID 33355126›Full record

ArticleScience advances2020

Human myotube formation is determined by MyoD-Myomixer/Myomaker axis.

Haifeng Zhang, Junfei Wen, Anne Bigot, Jiacheng Chen, Renjie Shang, Vincent Mouly, Pengpeng Bi

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Elevated MyoD1 levels expand genome-wide binding and the repertoire of regulated genes.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Haifeng ZhangCenter for Molecular Medicine, University of Georgia, Athens, GA 30602, USA.ORCID 0000-0002-5126-4490
Junfei WenCenter for Molecular Medicine, University of Georgia, Athens, GA 30602, USA.ORCID 0000-0001-8267-6124
Anne BigotCenter for Research in Myology UMRS974, Sorbonne Université, INSERM, Myology Institute AIM, Paris, France.ORCID 0000-0003-0337-5425
Jiacheng ChenCenter for Molecular Medicine, University of Georgia, Athens, GA 30602, USA.ORCID 0000-0002-7286-5551
Renjie ShangCenter for Molecular Medicine, University of Georgia, Athens, GA 30602, USA.ORCID 0000-0002-9184-4094
Vincent MoulyCenter for Research in Myology UMRS974, Sorbonne Université, INSERM, Myology Institute AIM, Paris, France.ORCID 0000-0003-3809-4033
Pengpeng BiCenter for Molecular Medicine, University of Georgia, Athens, GA 30602, USA. pbi@uga.edu.ORCID 0000-0002-9871-6773
University of Georgia · USInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myoblast fusion is essential for formations of myofibers, the basic cellular and functional units of skeletal muscles. Recent genetic studies in mice identified two long-sought membrane proteins, Myomaker and Myomixer, which cooperatively drive myoblast fusion. It is unknown whether and how human muscles, with myofibers of tremendously larger size, use this mechanism to achieve multinucleations. Here, we report an interesting fusion model of human myoblasts where Myomaker is sufficient to induce low-grade fusion, while Myomixer boosts its efficiency to generate giant myotubes. By CRISPR mutagenesis and biochemical assays, we identified MyoD as the key molecular switch of fusion that is required and sufficient to initiate Myomixer and Myomaker expression. Mechanistically, we defined the E-box motifs on promoters of Myomixer and Myomaker by which MyoD induces their expression for multinucleations of human muscle cells. Together, our study uncovered the key molecular apparatus and the transcriptional control mechanism underlying human myoblast fusion.

Identifiers

PMID33355126
PMCPMC11206528
OpenAlexW3113036715

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.